Candel Therapeutics, Inc. · NASDAQ:CADL
Baker Bros. Advisors LP's stake in Candel Therapeutics, Inc. fell to 4.99% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Baker Bros. Advisors LP's stake in Candel Therapeutics, Inc. fell to 4.99%, 2,455,108 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 2,455,108
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 4.99% | 2,455,108 |
| Baker Bros. Advisors (GP) LLC | 4.99% | 2,455,108 |
| Julian C. Baker | 4.99% | 2,455,108 |
| Felix J. Baker | 4.99% | 2,455,108 |
Source
Related
- Candel Therapeutics, Inc.
- Baker Bros. Advisors LP
- Candel Therapeutics, Inc. shareholders
- Schedule 13G · Baker Bros. Advisors LP · Feb 14, 2025
- Form 4 · Tak Paul Peter · Sep 11, 2026
- Form 4 · Tyagarajan Seshu · Aug 19, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Barone Francesca · Jul 1, 2026
- Form 4 · Tyagarajan Seshu · Jul 1, 2026